$82.44
$0.00 (0.00%)
End-of-day quote: 05/04/2024
NasdaqGS:BMRN
BioMarin Pharmaceutical Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | CPSE | Outperform | kr850.60 | kr696.07 | 0.00% | 14 | kr3.78T |
| PFE | Pfizer | NYSE | Outperform | $27.81 | $32.87 | 0.00% | 6 | $157.48B |
| SAN | Sanofi | ENXTPA | Outperform | 91.30€ | 102.80€ | 0.00% | 9 | 114.00€B |
| CSL | CSL | ASX | Outperform | $275.80 | $205.51 | 0.00% | 5 | $133.28B |
| 4568 | Daiichi Sankyo Company | TSE | Buy | ¥5.50k | ¥5.24k | 0.00% | 0 | ¥10.55T |
| MRNA | Moderna | NasdaqGS | Outperform | $125.00 | $135.42 | 0.00% | 1 | $47.90B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.13k | ¥4.74k | 0.00% | 0 | ¥6.47T |
| BIIB | Biogen | NasdaqGS | Outperform | $217.51 | $299.62 | 0.00% | 13 | $31.67B |
| BAYN | Bayer | XTRA | Hold | 28.02€ | 45.15€ | 0.00% | 4 | 27.53€B |
| ALNY | Alnylam Pharmaceuticals Inc | NASDAQ | Outperform | $152.33 | $245.24 | 0.00% | 7 | $19.27B |
| SRPT | Sarepta Therapeutics | NasdaqGS | Outperform | $133.66 | $158.66 | 0.00% | 6 | $12.63B |
| SOBI | Swedish Orphan Biovitrum AB (p... | OM | Outperform | kr280.00 | kr293.00 | 0.00% | 6 | kr97.00B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $41.97 | $55.60 | 0.00% | 3 | $6.12B |
| GRF | Grifols | BME | Outperform | 8.89€ | 18.48€ | 0.00% | 3 | 5.32€B |
| DYN | Dyne Therapeutics | NasdaqGS | Buy | $26.08 | $28.13 | 0.00% | 0 | $2.24B |
| DCPH | Deciphera Pharmaceuticals | NasdaqGS | Outperform | $25.38 | $23.40 | 0.00% | 4 | $2.09B |
| NTLA | Intellia Therapeutics | NasdaqGM | Outperform | $23.60 | $75.84 | 0.00% | 21 | $2.06B |
| 4516 | Nippon Shinyaku | TSE | Outperform | ¥4.39k | ¥8.34k | 0.00% | 0 | ¥293.93B |
| BCRX | BioCryst Pharmaceuticals | NasdaqGS | Outperform | $4.45 | $14.09 | 0.00% | 2 | $918.17M |
| PHARM | Pharming Group N.V. | ENXTAM | Buy | 0.90€ | 1.85€ | 0.00% | 2 | 590.27€M |
| WVE | Wave Life Sciences | NasdaqGM | Outperform | $6.14 | $9.21 | 0.00% | 3 | $602.86M |
| STOK | Stoke Therapeutics | NasdaqGS | Buy | $12.02 | $19.33 | 0.00% | 3 | $574.86M |
| ABUS | Arbutus Biopharma | NasdaqGS | Outperform | $2.71 | $6.34 | 0.00% | 0 | $511.42M |
| KALV | KalVista Pharmaceuticals | NasdaqGM | Buy | $12.13 | $20.80 | 0.00% | 0 | $478.84M |
| FULC | Fulcrum Therapeutics | NasdaqGM | Outperform | $7.75 | $10.21 | 0.00% | 7 | $443.16M |
| PYC | PYC Therapeutics | ASX | Buy | $0.11 | $0.30 | 0.00% | 1 | $294.90M |
